Clinical Trials Browser

Phase 2 × Acquired Immunodeficiency Syndrome × Nivolumab × Clear all

NCT03304093 2023-05-12

CHIVA2

Phase 2 Completed

Acquired Immunodeficiency Syndrome, Carcinoma, Non-Small-Cell Lung